SAFETY OF FLIBANSERIN IN WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER TAKING ANTIDEPRESSANT MEDICATIONS

被引:0
|
作者
Simon, J. A. [1 ]
Kingsberg, S. A. [2 ]
Millheiser, L. S. [3 ]
Clayton, A. H. [4 ]
机构
[1] George Washington Univ, IntimMed Specialists, Washington, DC USA
[2] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA
[3] Sprout Pharmaceut Inc, Raleigh, NC USA
[4] Univ Virginia, Sch Med, Charlottesville, VA 22903 USA
来源
JOURNAL OF SEXUAL MEDICINE | 2019年 / 16卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
144
引用
收藏
页码:S74 / S74
页数:1
相关论文
共 50 条
  • [42] Efficacy of flibanserin as a potential treatment for Hypoactive Sexual Desire Disorder in North American postmenopausal women
    Simon, James A.
    DeRogatis, Leonard
    Dennerstein, Lorraine
    Krychman, Michael
    Shumel, Brad
    Garcia, Miguel
    Hanes, Vladimir
    Sand, Michael
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (12): : 1346 - 1346
  • [43] EFFICACY OF FLIBANSERIN AS A POTENTIAL TREATMENT FOR HYPOACTIVE SEXUAL DESIRE DISORDER IN NORTH AMERICAN POSTMENOPAUSAL WOMEN
    Simon, James
    DeRogatis, Leonard
    Dennerstein, Lorraine
    Krychman, Michael
    Shumel, Brad
    Garcia, Miguel, Jr.
    Hanes, Vladimir
    Sand, Michael
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 168 - 168
  • [44] PATIENT'S PERSPECTIVE OF EFFICACY OF FLIBANSERIN IN PREMENOPAUSAL WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)
    Jolly, Elaine
    Clayton, Anita
    Thorp, John
    Nappi, Rossella
    Kimura, Toshio
    Sand, Michael
    Pyke, Robert
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 133 - 134
  • [45] SAFETY AND TOLERABILITY OF FLIBANSERIN IN PREMENOPAUSAL WOMEN WITH HYPOACTCFVE SEXUAL DESIRE DISORDER
    Jolly, Elaine
    Clayton, Anita
    Thorp, John
    Nappi, Rossella
    Kimura, Toshio
    Haynes, Vladimir
    Pyke, Robert
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 141 - 141
  • [46] Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder Commentary
    Shindel, Alan W.
    SEXUAL MEDICINE, 2022, 10 (06)
  • [47] Continued Efficacy and Safety of Flibanserin in Premenopausal Women with Hypoactive Sexual Desire Disorder (HSDD): Results from a Randomized Withdrawal Trial
    Goldfischer, Evan R.
    Breaux, Jeffery
    Katz, Molly
    Kaufman, Joel
    Smith, William B.
    Kimura, Toshio
    Sand, Michael
    Pyke, Rob
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 (11): : 3160 - 3172
  • [48] EFFICACY OF FLIBANSERIN 100 MG QHS AS A POTENTIAL TREATMENT FOR HYPOACTIVE SEXUAL DESIRE DISORDER IN PREMENOPAUSAL WOMEN
    Jolly, Elaine
    Clayton, Anita
    Thorp, John
    Nappi, Rossella
    Kimura, Toshio
    Sand, Michael
    Pyke, Robert
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 140 - 141
  • [49] Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis
    Kamrul-Hasan, A. B. M.
    Hannan, Mohammad Abdul
    Alam, Muhammad Shah
    Aalpona, Fatema Tuz Zahura
    Nagendra, Lakshmi
    Selim, Shahjada
    Dutta, Deep
    MEDICINE, 2024, 103 (25)
  • [50] EFFECT OF FLIBANSERIN ON BODY WEIGHT DURING TREATMENT FOR HYPOACTIVE SEXUAL DESIRE DISORDER IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN
    Kornstein, S. G.
    Simon, J. A.
    Apfel, S. C.
    Yuan, J.
    Barbour, K. A.
    Kissling, R.
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (02): : E97 - E97